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ABSTRACT – Background: Healing is an innate biological phenomenon, and carcinogenesis 
acquired, but with common humoral and cellular elements. Carcinogenesis interferes 
negatively in healing. Aim: To evaluate the histological changes in laparotomy scars of healthy 
Balb/c mice and with an Ehrlich tumor in its various forms of presentation. Methods: Fifty-four 
mice were divided into three groups of 18 animals. First group was the control; the second 
had Ehrlich tumor with ascites; and the third had the subcutaneous form of this tumor. Seven 
days after tumor inoculation, all 54 mice were submitted to laparotomy. All of the animals in 
the experiment were operated on again on 7th day after surgery, with resection of the scar 
and subsequent euthanasia of the animal. The scars were sent for histological assessment 
using immunohistochemical techniques to evaluate Cox-2 (cyclooxygenase 2), VEGF (vascular 
endothelial growth factor) and FGF (fibroblast growth factor). Semi-quantitatively analysis was 
done in the laparotomy scars and in the abdominal walls far away from the site of the operation. 
Results: Assessing the weight of the animals, the correct inoculation of the tumor and weight 
gain in the group with tumoral ascites was observed. The histological studies showed that 
groups with the tumor showed a statistically significant higher presence of Cox-2 compared 
to the control. In the Cox-2 analysis of the abdominal wall, the ascites group showed the 
most significant difference. VEGF did not present any significant differences between the three 
groups, regardless of the site. The FGF showed a significant increase in animals with the tumor. 
Conclusion: Histological findings in both laparotomy scar and the abdominal wall showed that 
with Ehrlich’s neoplasia there was an exacerbated inflammatory response, translated by more 
intense expression of Cox-2 and greater fibroblast proliferation, translated by more intense 
expression of FGF, that is, it stimulated both the immediate inflammatory reactions, observed 
with Cox-2 reactions, and late scarring by fibroblasts and FGF.
RESUMO – Racional: A cicatrização é fenômeno biológico inato, e a carcinogênese adquirido, 
mas com elementos humorais e celulares comuns. A carcinogênese interfere de forma negativa 
na cicatrização. Objetivo: Avaliar as modificações histológicas nas cicatrizes laparotômicas de 
camundongos Balb/c sadios como controles, e com a neoplasia de Ehrlich, em suas diferentes 
formas de apresentação. Métodos: Foram utilizados 54 camundongos, divididos em três grupos 
de 18 animais cada um. O primeiro era controle; o segundo com a neoplasia de Ehrlich em 
sua forma ascítica; e o terceiro na forma subcutânea. Sete dias após a inoculação do tumor, 
todos os 54 camundongos foram submetidos à laparotomia e reoperados no sétimo dia de pós-
operatório, com ressecção da cicatriz e posterior eutanásia. As cicatrizes foram encaminhadas 
para estudo histológico com técnicas  imunoistoquímicas para avaliar Cox-2 (ciclo-oxigenase 2), 
VEGF (fator de crescimento do endotélio vascular) e FGF (fator de crescimento dos fibroblastos) 
e analisadas de forma semiquantitativana tanto na cicatriz laparotômica como na parede 
abdominal mais distante do local operado. Resultados: Avaliando o peso, observou-se a correta 
inoculação do tumor e o aumento de peso no grupo com a neoplasia na modalidade ascítica. Os 
estudos histológicos mostraram que os grupos com a neoplasia apresentaram maior presença 
da Cox-2 em relação ao controle, estatisticamente significante. No estudo da Cox-2 da parede 
abdominal foi o local em que o grupo ascítico apresentou a diferença mais expressiva. O VEGF 
não apresentou diferenças significantes entre os três grupos, independentemente do local 
estudado. O FGF teve aumento significante nos animais com neoplasia. Conclusão: Os achados 
histológicos encontrados tanto na cicatriz das laparotomias quanto na parede abdominal 
mostraram que com a neoplasia de Ehrlich houve resposta inflamatória exacerbada, traduzida 
por expressão mais intensa da Cox-2 e maior proliferação fibroblástica, traduzida por expressão 
mais intensa do FGF, ou seja, estimulou tanto as reações inflamatórias imediatas, observadas nas 
reações da Cox-2, como nas cicatriciais tardias com os fibroblastos e o FGF.
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INTRODUCTION
Healing is defined as the organism’s capacity to repair tissues after inflammation3,4,13. Wound healing is a complex repairing phenomenon, involving 
inflammatory reaction, a proliferative process and then tissue 
remodeling22. Complete regeneration, which could be defined 
as the formation of a tissue with identical structure and function 
to the original, is uncommon22. Rather, cicatrization or healing 
is a process in which the integrity of the tissue is obtained in a 
similar manner, with small modifications depending on the site, 
the tissue of the wound, and the agent causing it3,4,13.
Studies described five stages of healing, beginning with the 
acute inflammatory phase, then cellular proliferation, formation 
of conjunctive tissue, contraction and final remodeling of the 
wound. These phases are mixed and not individualized; they occur 
together and overlap each other. Some authors cite four phases: 
cleaning, granulation tissue, re-epithelialization and retraction8,10,22.
Granulation tissue is the new tissue that grows and fills the 
defect from the wound. It includes the proliferation of fibroblasts 
and capillaries. The capillaries originate from endothelial cells. 
Angiogenesis appears to be similar in the granulation of wounds 
and the creation of stroma for neoplastic cells in the growth of 
malignant tumors2.
In the healing process various mediators are synthesized in 
the damaged region, which modulate the inflammatory cascade in 
the early stage of injury repair and the formation of a permanent 
scar7. Of these, Cox 2 and pro-inflammatory cytokines, such 
as interleukins, growth factors and tumor necrosis factor, are 
fundamental for cell proliferation and synthesis of the extracellular 
matrix. Cytokines acting on injuries and malignant tumors can 
reduce the expression of p53, a regulator of cell replication18,28,31.
The reduced VEGF decreases expression and protein synthesis 
and the deposition of collagen, worsening healing. Research shows 
that the introduction of VEGF in the tissue of animals causes a 
local increase in vascularization29,30. Several solid tumor studies 
have demonstrated the importance of VEGF in the angiogenesis 
of tumors1. The formation of the extracellular matrix and collagen 
deposition depend on the inflammatory reaction11. In the stage 
of cellular proliferation and connective tissue formation, wound 
healing is similar in some respects to that observed in some tumors.
The objective of this study was to compare the histological 
changes in laparotomy scars in healthy mice and those with 
Ehrlich tumors.
METHODS
The experiment followed the ethical principles for animal 
experiments and animal care and pain control, and the local 
legislation. The project was approved by the university’s Ethics 
Committee (protocol number 2009/09).
Study design and animals
This is an experimental, controlled study with female Balb/c 
mice. All animals were from the same university bioterium, weighing 
18-22 g, aged nine weeks old. Before the experiment, the animals 
spent seven days in the laboratory to acclimatize to the environment. 
The space had controlled temperature (between 20-24 degrees 
Celsius) and humidity (at 50-60%), with dark/light cycles of 12 h, 
and mice had free access to standardized dry pellet diet and water. 
They were kept in individual cages and were evaluated daily and 
weighed four times during the experiment. Operated animals 
were kept in a different room of the rats awaiting surgery. The 
animals were fastened for food for 6 h and for water for 1 h before 
surgery. A pilot study with six animals was performed before the 
experiment for the standardization of anesthetic, surgical and 
histopathologic analysis techniques.
Three groups were studied with 18 animals each: control 
group (C); group with introduction of Ehrlich tumor cell into the 
peritoneum6,9,12,26 (A); and group where the same cell was introduced 
into the subcutaneous tissue of the left thigh (D). The introduction 
of the malignant cell in the two proposed models was performed 
according to an original work developed in 1896 and published in 
1906 by Paul Ehrlich9 and followed by other research models6,12,26. 
Seven days after the introduction of the tumor cell or saline buffer 
acid, all 54 animals were subjected to median laparotomy. A week 
after surgery, the animals were operated once again with resection 
of the anterior abdominal wall tissue, including the surgical scar. 
This tissue block was sent for histological study.
Neoplastic cells inoculation
Neoplastic cells with 92% of cell viability (counted in Neubauer 
chamber) were provided by the Veterinarian School of the University. 
The solution (0.4 ml) was injected into the peritoneum (in the the 
lower left quadrant of the abdomen) or into the subcutaneous layer 
of the left thigh (hind leg) of the mice (lateral external regional). 
Surgical procedure, postoperative care and euthanasia
Before anesthesia, rats were sedated with atropine (0.04 
mg/kg or 0.0012 mg for an animal weighing 30 g). Xylazine (50 
mg/kg) and ketamine (10 mg/kg) were used for anesthesia. Drugs 
were administered intramuscularly in the right thigh of the mice. 
All animals underwent laparotomy, with a median incision of 
2.5 cm. The abdominal contents were inspected in all animals, and 
the ascites liquid observed in the group that received neoplastic 
cells in the peritoneum was not eliminated. Two surgeons operated 
using esterile technique. The abdominal wall was closed on two 
planes with four stiches of Mononylon Ethicon 5-0 suture, 0.6 cm 
apart from each other approximately. The first plane involved the 
peritoneum wall, aponeurosis and muscles; and the second, the 
subcutaneous tissue and skin.
Animals were put back in their cages 30 minutes after 
surgery. Tramadol hydrochloride (1 mg/kg, each 12 hours) was 
used as analgesic for three days after surgery, added to the animals’ 
water5. The surgical wound was kept exposed, with no dressings. 
Seven days after the first surgery, animals were euthanized 
with quadruplicated dosages of the drugs used in anesthesia. 
The surgical scar and tissues around it were removed en bloc for 
histological analysis, measuring approximately 3 cm in extension, 
from the xiphoid process. 
Histological analysis
The tissue removed from the abdominal wall and the 
surgical scar of all animals was histologically analyzed. They were 
preserved in Carnoy solution for 12 h and then absolute alcohol 
(95%), and then submitted to dehydration, diaphanization with 
xylene and paraffin embedding. The slides were mounted with 
5-micra thick sections, submitted to staining with hematoxylin 
and eosin (HE) and Masson’s trichrome for scar identification. 
Immunohistochemistry study was performed for the detection 
of cyclooxygenase 2 (Cox-2 SP21, M3214 Spring clone, diluted 
at 1/250), vascular endothelial growth factor (VEGF C-1, SC7269 
Santa Cruz clone, diluted at 1/100) and fibroblast growth factor 
(FGF 2, 147 Santa Cruz clone, diluted at 1/1500). 
Reactions were classified as light, moderate or intense, with 
scores varying from 1 to 314,16,20,, in the scar and in the abdominal 
wall (for Cox 2 and VEGF) and in the inflammation infiltrate in 
scar tissue only for FGF.
Statistical analysis
The Student’s t-test was used to evaluate the weight of the 
animals within each group. ANOVA and Tukey’s test were used 
for the analysis between the three groups. In the analysis of the 
histological parameters, the binomial test was used to test the 
differences between the independent sample proportions. BioEstat 
software, version 5.0, was used in statistical analysis, considering 
as significant p-values equal to or less than 0.05.
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The FGF analysis showed that the scars of animals with 
tumors presented significant differences compared to the 
control (p<0.05). When compared, the groups with tumors 
showed no significant difference (p>0.05, Figures 4A and 4B). 
FIGURE 4 – A) FGF, group D, 400x, ++; B) FGF, group A, 400x, 
+++
DISCUSSION
The exclusive evaluation of the scar was impaired in group 
A owing to the invasion of the scar by neoplastic cells present 
in the ascites. This was the group where the tumor developed 
most rapidly with evident worsening of animals due to ascites 
and the symptoms induced by such. The abdominal wall distant 
from the scar was also assessed.
Cox-2 is an enzyme involved in the inflammatory response, 
also expressed in the cell division mechanisms of malignant 
tumors, where it plays an important role. It is usually not 
detected and increases in the carcinogenesis processes, when 
cytokines, stimuli and tumor growth factors exist, and acting in 
association with neoplastic tumor cells, can regulate the initial 
growth of these cells, their proliferation, invasion, migration, 
angiogenic phenomena and finally apoptosis and programmed 
death of the cells19,21,27. In this study, the expression of Cox-2 was 
intense, at maximum level in most scars of animals with tumors 
from group A and group D. Expression was lower in group C. 
Angiogenesis consists in the formation of new vessels, 
driven by cellular factors such as macrophages, mast cells, 
platelets, fibroblasts and neoplastic cells that produce more 
than a dozen factors that interfere in the process, especially 
VEGF, FGF, and transforming growth factors β15,25. 
VEGF induces cell proliferation, cell migration, embryo 
development, cell differentiation, angiogenesis and malignant 
transformation. Angiogenesis is a fundamental biological 
correlate to malignancy and tumor progression. The capillaries 
originating from endothelial cells form and irrigate a stroma 
for the growth of neoplastic cells24. The differences in the 
inflammatory phase, as evaluated using Cox-2 in this experiment, 
were not repeated in the evaluation of VEGF in the scars. In 
the study of the entire abdominal wall, VEGF was found to be 
identical in all three groups. Infiltration of the abdominal wall 
by the tumor observed in group A also produced no differences 
in this finding.
FGF is a member of the family of growth factors that 
stimulate the proliferation of mesenchymal cells and epithelial 
cells. It stimulates the growth and maturation of fibroblasts, 
in conjunction with other cytokines. It was observed that all 
the conditions were created for the fibroblasts to have an 
increased expression in groups with tumors17,23. In this study, 
the evaluation of FGF is increased in the groups with tumors, 
that is, higher than in the control group.
The phases of healing, with humoral and vascular phenomena, 
should not be evaluated as closed and fractionated departments. The 
phenomena occur simultaneously, are self-regulating and interfere 
with each other. Separating cytokines from cells is impossible, because 
there is a fundamental interaction, not only for the healing process 
itself, but for its perfect understanding. In this study, the analysis of 
all the variables together demonstrates the possible interference 
of the neoplastic process with the operative scar.
RESULTS
There were no deaths among the 54 animals during the 
experiment. There were no surgical or anesthetic complications. 
Animals in the group with ascites experienced weight gain of 
10 g in average comparing baseline with the reoperation day 
(Figure 1). Weight in this group was significantly higher than 
in the other groups in the reoperation day (p<0.05). The H&E 
and Masson trichrome techniques were able to identify the 
surgical scar accurately (Figure 2A). In the Cox-2 evaluation 
within each group it was noted that in group A there was 
significant difference between the abdominal wall and the 
surgical wound data (p<0.05, Figures 2B and 2C). 
FIGURE 1 - Weight on arrival and reoperation in all three groups
FIGURE 2 – Surgical scar: A) Masson’s trichrome, group D, 40x 
D; B) Cox-2, group A, 40x,+++; C) Cox-2, group 
A, 40x, ++ 
Comparing the three groups, there was a significant 
difference in the abdominal wall between groups A, D and C 
(p< 0.05), with higher expression in group A compared to D, 
and group D to C.
In the evaluation of the surgical scar, the tumor cell 
groups A and D showed no significant difference between 
them (p>0.05), but were higher when compared with group 
C (p< 0.05).
The analysis with VEGF showed no differences between 
the three groups in the surgical wound or abdominal wall (p> 
0.05, Figure 3).
FIGURE 3 - VEGF, group A, 40x,++
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The analysis of the histological f indings using 
immunohistochemical methods, both in the laparotomy scars 
and in the abdominal wall, allows us to conclude that, in mice 
with Ehrlich tumors, there was exacerbated inflammatory 
response, reflected by the increased expression of Cox-2, as well 
as greater fibroblast proliferation, reflected by the increased 
expression of FGF. We did not detect changes in the vasculature 
due to lack of significant differences in the analysis of VEGF 
between groups. The exaggerated inflammatory response in 
the tumor groups explains the possible presence of a larger 
number of fibroblasts in this scar, producing increased secretion 
of collagen and fibrosis.
CONCLUSION
Histological findings in both laparotomy scar and the 
abdominal wall showed that with Ehrlich’s neoplasia there was an 
exacerbated inflammatory response, translated by more intense 
expression of Cox-2 and greater fibroblast proliferation, translated 
by more intense expression of FGF, that is, it stimulated both 
the immediate inflammatory reactions, observed with Cox-2 
reactions, and late scarring by fibroblasts and FGF.
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